Development of a preventive vaccine for Ebola virus infection in primates

Nature

Volumn 408, Issue 6812, 2000, Pages 605-609

  Sullivan, Nancy J ^a   Sanchez, Anthony ^b   Rollin, Pierre E ^b   Yang, Zhi Yong ^a   Nabel, Gary J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EBOLA VIRUS; HUMORAL IMMUNITY; INFECTION PREVENTION; MACACA; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; VACCINATION; VIRUS HEMORRHAGIC FEVER; VIRUS LOAD; VIRUS STRAIN;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; DEMOCRATIC REPUBLIC OF THE CONGO; DNA, VIRAL; EBOLAVIRUS; GENETIC VECTORS; GUINEA PIGS; HEMORRHAGIC FEVER, EBOLA; IMMUNIZATION, SECONDARY; MACACA FASCICULARIS; MICE; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID PROTEINS; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; EBOLA VIRUS; MACACA; PRIMATES; RNA VIRUSES;

EID: 0034735774     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35046108     Document Type: Article

References (29)

1. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein
2. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing
3. Genetic immunization is a simple method for eliciting an immune response
4. Heterologous protection against influenza by injection of DNA encoding a viral protein
5. Gene inoculation generates immune responses against human immunodeficiency virus type 1
6. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
7. CpG motifs in bacterial DNA trigger direct B-cell activation
8. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
9. Immunization for Ebola virus infection
10. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge
11. Pathogenesis of experimental Ebola virus infection in guinea pigs
12. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
13. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
14. Ebola virus can be effectively neutralized by antibody produced in natural human infection
15. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
16. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
17. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
18. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
19. Expression of hepatitis B surface antigen with a recombinant adenovirus
20. Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model
21. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
22. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant
23. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
24. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola)
25. Epitopes involved in antibody-mediated protection from Ebola virus
26. Gene therapy for vascular smooth muscle cell proliferation after arterial injury
27. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro
28. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates
29. Ebola virus: Identification of virion structural proteins